SCHEMBL6817814

SCHEMBL6817814

Clc1nc(NCCc2ccccn2)c2ncn(C3CCCC3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 7/20 0.51
TSHR P16473 2/20 0.50
CYP1A2 P05177 1/20 0.50
CTSL P07711 3/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SRC P12931 1/20 0.45
CHKA P35790 1/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
GFER P55789 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CCNE1 P24864 3/20 0.44
CDK2 P24941 3/20 0.44
NT5E P21589 1/20 0.44
CCNB2 O95067 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817845 0.86 CYP2D6 (0.64) CDK1TSHRCYP1A2CTSLCYP2D6
SCHEMBL6944712 0.83 CDK1 (0.57) CDK1TSHRCTSLCYP2D6CYP2C9
SCHEMBL6821666 0.82 ADORA3 (0.60) CDK1TSHRCTSLCYP2D6CYP2C9
SCHEMBL8201684 0.82 ADORA3 (0.64) CDK1TSHRCTSLCYP2D6CYP2C9
SCHEMBL6821051 0.82 ADORA3 (0.64) CDK1TSHRCTSLCYP2D6CYP2C9
SCHEMBL6821695 0.81 CDK2 (0.70) CDK1SRCCCNE1CDK2CCNB2
SCHEMBL6821691 0.81 CDK2 (0.70) CDK1SRCCCNE1CDK2CCNB2
Hydrochloric Acid SCHEMBL6820843 0.81 CDK2 (0.69) CDK1SRCCCNE1CDK2CCNB2
Hydrochloric Acid SCHEMBL6820844 0.81 CDK2 (0.69) CDK1SRCCCNE1CDK2CCNB2
SCHEMBL6821652 0.80 CTSL (0.52) CDK1TSHRCTSLCYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056745-B1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMA INC (US) 2004-06-16 EP disclosed
US-6413974-B1 INHIBITORS OF CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; PREVENTING APOPTOSIS IN NEURONAL CELLS; ANTINEOPLASTIC AGENTS; NEURONAL INJURY AND DEGENERATION; CEREBROVASCULAR DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 US disclosed
EP-1056745-A2 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043676-A2 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed